[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-368349-105":59,"doc-detail-368349-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","gd2-is-a-crucial-ganglioside-in-the-signal-modulation-and-application-as-a-target-of-cancer-therapeutics-cancer-science-review","GD2 is a Crucial Ganglioside in the Signal Modulation and Application as a Target of Cancer Therapeutics - Cancer Science Review","","While disialylated gangliosides have been established as cancer-associated carbohydrate antigens suitable for tumor markers, GD3 and GD2 receive particular attention for their roles in both cancer and normal tissues. GD2 shows more restricted expression than GD3, supporting broader applicability of anti-GD2 immunotherapy. Recent reports link GD2 to epithelial and neuroectoderm-derived tumors and to cancer stem cell–related properties through signal modulation. Anti-GD2 antibody and anti-GD2 CAR-T therapies are actively developed with combinations including cytokines, chemotherapy, and immune checkpoint blockade.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/gd2-is-a-crucial-ganglioside-in-the-signal-modulation-and-application-as-a-target-of-cancer-therapeutics-cancer-science-review/368349/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/gd2-is-a-crucial-ganglioside-in-the-signal-modulation-and-application-as-a-target-of-cancer-therapeutics-cancer-science-review/368349.png","ImageObject",300,407,{"name":92,"@type":93},"Genevieve","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-31","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":24},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"Why is GD2 considered a promising target for cancer immunotherapy?","Question",{"text":112,"@type":113},"GD2 is expressed in more restricted cells than GD3, making anti-GD2 immunotherapy more applicable. It is also reported in various epithelial cancers and neuroectoderm-derived tumors.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How are GD2 and GD3 related to cancer cell regulation?",{"text":117,"@type":113},"GD2/GD3 are recognized not only as cancer-associated antigens but also as regulatory molecules influencing biological features of cancer cells and the body. The review highlights GD2’s involvement in signal modulation associated with cancer stemness.",{"name":119,"@type":110,"acceptedAnswer":120},"What therapeutic approaches target GD2 and how are they being improved?",{"text":121,"@type":113},"Cancer immunotherapy targeting GD2 includes anti-GD2 antibodies and anti-GD2 CAR-T. Current development explores modifications such as combination with cytokines, chemotherapy, and immune checkpoint blocking.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},368349,1790408061,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":24,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":44,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":144,"preview_page_count":19,"preview_urls":145},1374391974585,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","Cancer Science  \nGD2 is a Crucial Ganglioside in the Signal Modulation and Application as a Target of Cancer Therapeutics  \nKoichi Furukawa1,2  | Yuhsuke Ohmi3 | Kazunori Hamamura4 | Yuki Ohkawa5 | Noboru Hashimoto6 | Orie Tajima1 | Kei Kaneko1 | Keiko Furukawa1  \n1Department of Biomedical Sciences, Chubu University College of Life and Health Sciences, Matsumoto, Kasugai, Japan | 2Department of Molecular Biochemistry, Nagoya University Graduate School of Medicine, Nagoya, Japan | 3Department of Clinical Engineering, Chubu University College of Life and Health Sciences, Matsumoto, Kasugai, Japan | 4Department of Pharmacology, Aichi Gakuin University School of Dentistry, Nagoya, Japan | 5Department of GlycoOncology, Osaka International Cancer Center Institute, Osaka, Japan | 6Department of Tissue Regeneration, Tokushima University Graduate School of Biomedical Science, Tokushima, Japan  \nCorrespondence: Koichi Furukawa ([koichi@fsc.chubu.ac.jp](koichi@fsc.chubu.ac.jp))  \nReceived: 21 November 2024 | Revised: 22 January 2025 | Accepted: 28 January 2025  \nFunding: This study was supported by Grants-in-Aids from the Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT; 19K22518, 19K07393, 21K26828) and by JST-CREST (Grant Number: JPMJCR17H2). This study was also supported by the Interdisciplinary Joint Research Program of the J-Glyconet cooperative network, which was accredited by MEXT, Japan.  \nKeywords: cancer antigen | ganglioside | immunotherapy | lipid rafts | signal  \nABSTRACT  \nWhile various glycosphingolipids were identified as cancer-associated carbohydrate antigens to be used as tumor markers, disialylated gangliosides such as GD3 and GD2 have particularly attracted attention from many researchers as promising cancerassociated antigens. Simultaneously, their functions in cancer and normal tissues have also been reported. Although GD3 is expressed at the early neural developmental stage and in various cancers, it is also found in the activated status of some normal cells such as astrocytes and lymphocytes. On the other hand, GD2 is expressed in more restricted cells than GD3, enabling anti-GD2 immune therapy to be more applicable for immunotherapy. Recently, the expression of GD2 has been reported in various epithelial cancers and neuroectoderm-derived tumors. The involvement of GD2 in cancer stem cell propertiesand the roles of GD2 in the signal modulation to bring about cancer stemness are now some of the most fascinating research topics. Cancer immunotherapy targeting GD2 by anti-GD2 antibody or anti-GD2 CAR-T is now widely being challenged with various modifications such as combination with cytokines, chemotherapy, or immune checkpoint blocking.  \n1 | Introduction  \nGangliosides are widely expressed in a number of tissues and cells in the bodies of vertebrates [1] . Although the majority of cells constituting our bodies express some kinds of gangliosides, nervous systems generally express high levels of gangliosides compared with other tissues [1, 2], and this fact is a common and unique finding throughout all vertebrate species.  \nAs cDNAs of glycosyltransferases responsible for the synthesis of gangliosides were isolated [3, 4], genetic modification of gangliosides in cultured cells and in experimental animals became possible, and many studies have been performed to clearly elucidate ganglioside functions [5, 6]. In particular, gene targeting of glycosyltransferase genes enabled us to directly access the roles of gangliosides in our bodies [7]. The synthetic pathway of main glycosphingolipids (GSLs) is shown in Figure 1.  \n\n| Abbreviations: ECM, extracellular matrix; EMARS/MS, enzyme-mediated activation of radical sources/mass spectrometry; FAK, focal adhesion kinase; PDGF(R), platelet-derived growth factor (receptor) . |\n| --- |\n| This is an open access article under the terms of the Creative Commons Attribution-NonCommercial License, which permits use, distribution and reproduction in any m","cbCaichHCrRtVOno","https://ap.wps.com/l/cbCaichHCrRtVOno","pdf",2290729,"English","# Introduction\n## Ganglioside expression and cancer-associated antigens\n## GD2/GD3 functions and therapeutic targeting\n## Anti-GD2 immunotherapy strategies","[{\"question\":\"Why is GD2 considered a promising target for cancer immunotherapy?\",\"answer\":\"GD2 is expressed in more restricted cells than GD3, making anti-GD2 immunotherapy more applicable. It is also reported in various epithelial cancers and neuroectoderm-derived tumors.\"},{\"question\":\"How are GD2 and GD3 related to cancer cell regulation?\",\"answer\":\"GD2/GD3 are recognized not only as cancer-associated antigens but also as regulatory molecules influencing biological features of cancer cells and the body. The review highlights GD2’s involvement in signal modulation associated with cancer stemness.\"},{\"question\":\"What therapeutic approaches target GD2 and how are they being improved?\",\"answer\":\"Cancer immunotherapy targeting GD2 includes anti-GD2 antibodies and anti-GD2 CAR-T. Current development explores modifications such as combination with cytokines, chemotherapy, and immune checkpoint blocking.\"}]","GD2 is a Crucial Ganglioside in the Signal Modulation and Application as a Target of Cancer Therapeutics - Cancer Science Review | PDF",1790176445,23,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/26e8223806e28547e64b400395d577c9.webp",983,1291,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4dc6ac76f767ea963304b99f9780aa83.webp",982,1290,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2821cc66d014a70e8ac717c40bdc7943.webp",981,1289,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f28696fc896a7affe453edadbd6268b6.webp",980,1287]